Making Solid Tumour Immunotherapy Safer and More Accessible

Time: 1:45 pm
day: Day 2 - Track B - Afternoon

Details:

  • TAC T-cell Antigen Coupler technology works directly with the T cell receptor to aid tumour recognition and targeting
  • Closely mirroring the natural T cell response TAC technology offers key advantages including reduced risk of tonic signalling, reduced risk from cytokine release, and retention of memory phenotype on engineered cells
  • TAC design offers potential for both autologous and allogeneic application

Speakers: